Literature DB >> 33546473

Lycopene Improves In Vitro Development of Porcine Embryos by Reducing Oxidative Stress and Apoptosis.

Hyo-Gu Kang1,2, Sanghoon Lee1, Pil-Soo Jeong1, Min Ju Kim1, Soo-Hyun Park1, Ye Eun Joo1, Sung Hyun Park1, Bong-Seok Song1, Sun-Uk Kim1,3, Min Kyu Kim2, Bo-Woong Sim1.   

Abstract

In vitro culture (IVC) for porcine embryo development is inferior compared to in vivo development because oxidative stress can be induced by the production of excessive reactive oxygen species (ROS) under high oxygen tension in the in vitro environment. To overcome this problem, we investigated the effect of lycopene, an antioxidant carotenoid, on developmental competence and the mechanisms involved in mitochondria-dependent apoptosis pathways in porcine embryos. In vitro fertilized (IVF) embryos were cultured in IVC medium supplemented with 0, 0.02, 0.05, 0.1, or 0.2 μM lycopene. The results indicate that 0.1 μM lycopene significantly increased the rate of blastocyst formation and the total cell numbers, including trophectoderm cell numbers, on Day In terms of mitochondria-dependent apoptosis, IVF embryos treated with 0.1 μM lycopene exhibited significantly decreased levels of ROS, increased mitochondrial membrane potential, and decreased expression of cytochrome c on Days 2 and Furthermore, 0.1 μM lycopene significantly decreased the number and percentage of caspase 3-positive and apoptotic cells in Day-6 blastocysts. In addition, Day-2 embryos and Day-6 blastocysts treated with 0.1 μM lycopene showed significantly reduced mRNA expression related to antioxidant enzymes (SOD1, SOD2, CATALASE) and apoptosis (BAX/BCL2L1 ratio). These results indicate that lycopene supplementation during the entire period of IVC enhanced embryonic development in pigs by regulating oxidative stress and mitochondria-dependent apoptosis.

Entities:  

Keywords:  antioxidant; lycopene; mitochondria-dependent apoptosis; pig; reactive oxygen species; reproduction

Year:  2021        PMID: 33546473      PMCID: PMC7913612          DOI: 10.3390/antiox10020230

Source DB:  PubMed          Journal:  Antioxidants (Basel)        ISSN: 2076-3921


  51 in total

1.  In vitro development of in vitro-matured porcine oocytes following chemical activation or in vitro fertilization.

Authors:  H Funahashi; T C Cantley; T T Stumpf; S L Terlouw; B N Day
Journal:  Biol Reprod       Date:  1994-05       Impact factor: 4.285

2.  Heat stress and antioxidant enzyme activity in bubaline (Bubalus bubalis) oocytes during in vitro maturation.

Authors:  Syma Ashraf Waiz; Mohammad Raies-Ul-Haq; Suman Dhanda; Anil Kumar; T Sridhar Goud; M S Chauhan; R C Upadhyay
Journal:  Int J Biometeorol       Date:  2016-01-19       Impact factor: 3.787

3.  Serum lycopene concentrations and carotid atherosclerosis: the Kuopio Ischaemic Heart Disease Risk Factor Study.

Authors:  Tiina H Rissanen; Sari Voutilainen; Kristiina Nyyssönen; Riitta Salonen; George A Kaplan; Jukka T Salonen
Journal:  Am J Clin Nutr       Date:  2003-01       Impact factor: 7.045

4.  Hydrogen peroxide levels in mouse oocytes and early cleavage stage embryos developed in vitro or in vivo.

Authors:  M H Nasr-Esfahani; J R Aitken; M H Johnson
Journal:  Development       Date:  1990-06       Impact factor: 6.868

5.  Dual effect of fetal bovine serum on early development depends on stage-specific reactive oxygen species demands in pigs.

Authors:  Seong-Eun Mun; Bo-Woong Sim; Seung-Bin Yoon; Pil-Soo Jeong; Hae-Jun Yang; Seon-A Choi; Young-Ho Park; Young-Hyun Kim; Philyong Kang; Kang-Jin Jeong; Youngjeon Lee; Yeung Bae Jin; Bong-Seok Song; Ji-Su Kim; Jae-Won Huh; Sang-Rae Lee; Young-Kuk Choo; Sun-Uk Kim; Kyu-Tae Chang
Journal:  PLoS One       Date:  2017-04-13       Impact factor: 3.240

6.  Mito-TEMPO improves development competence by reducing superoxide in preimplantation porcine embryos.

Authors:  Seul-Gi Yang; Hyo-Jin Park; Jin-Woo Kim; Jae-Min Jung; Min-Ji Kim; Ho-Guen Jegal; In-Su Kim; Man-Jong Kang; Gabbine Wee; Hee-Young Yang; Yun-Han Lee; Ji-Hae Seo; Sun-Uk Kim; Deog-Bon Koo
Journal:  Sci Rep       Date:  2018-07-04       Impact factor: 4.379

Review 7.  Three-parent babies: Mitochondrial replacement therapies.

Authors:  Hana Carolina Moreira Farnezi; Ana Carolina Xavier Goulart; Adriana Dos Santos; Mariana Gontijo Ramos; Maria Lectícia Firpe Penna
Journal:  JBRA Assist Reprod       Date:  2020-05-01

Review 8.  Achieving the balance between ROS and antioxidants: when to use the synthetic antioxidants.

Authors:  Borut Poljsak; Dušan Šuput; Irina Milisav
Journal:  Oxid Med Cell Longev       Date:  2013-04-29       Impact factor: 6.543

9.  Validation of reference genes for quantitative RT-PCR studies in porcine oocytes and preimplantation embryos.

Authors:  Ewart W Kuijk; Leonie du Puy; Helena T A van Tol; Henk P Haagsman; Ben Colenbrander; Bernard A J Roelen
Journal:  BMC Dev Biol       Date:  2007-05-31       Impact factor: 1.978

Review 10.  Reactive Oxygen Species Generation and Use of Antioxidants during In Vitro Maturation of Oocytes.

Authors:  Mozafar Khazaei; Faranak Aghaz
Journal:  Int J Fertil Steril       Date:  2017-02-16
View more
  4 in total

Review 1.  Challenges and Considerations during In Vitro Production of Porcine Embryos.

Authors:  Paula R Chen; Bethany K Redel; Karl C Kerns; Lee D Spate; Randall S Prather
Journal:  Cells       Date:  2021-10-15       Impact factor: 6.600

2.  Recent insights into the biological and pharmacological activity of lycopene.

Authors:  Jae Kwang Kim; Sang Un Park
Journal:  EXCLI J       Date:  2022-02-16       Impact factor: 4.068

3.  Progesterone Induces Apoptosis and Steroidogenesis in Porcine Placental Trophoblasts.

Authors:  Yueshuai Liu; Hongxiang Ding; Yuze Yang; Yan Liu; Xin Cao; Tao Feng
Journal:  Animals (Basel)       Date:  2022-10-08       Impact factor: 3.231

Review 4.  Effects of Lycopene Attenuating Injuries in Ischemia and Reperfusion.

Authors:  Sijia Wu; Xiajun Guo; Jia Shang; Yuanyuan Li; Wanglin Dong; Qianwen Peng; Zhenxing Xie; Chaoran Chen
Journal:  Oxid Med Cell Longev       Date:  2022-10-07       Impact factor: 7.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.